Pfizer Inc. (NYSE: PFE) Enters a Megabucks Deal to Ramp Up Generics Portfolio

World’s number one pharmaceutical establishment, Pfizer Incorporated (NYSE: PFE) has bargained a collaboration with India’s Strides Arcolab Ltd in which the New Yolk-based company will be supplied with 40 off-patent injectable and oral drugs for sale to patients and healthcare providers in the U.S. This deal which financial terms were not revealed is envisaged to go a long way in bolstering Pfizer’s generic drugs portfolio. The company reckons that the market for such medicines in the country is valued at more or less than $10.9 billion on the whole.